New patent for Emergent drug NARCAN
Annual Drug Patent Expirations for NARCAN Narcan is a drug marketed by Adapt, Bristol Myers Squibb, and Emergent and, and is included in five NDAs. It is available from seven…
The post New patent for Emergent drug NARCAN appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.